Technology

  Market Overview According to MarketGenics , the global Urinary Tract Infection (UTI) Prevention Products Market was valued at USD 4.8 billion in 2025 and is projected to reach USD 11.7 billion by 2035 , expanding at a CAGR of 9.3% during the forecast period. The market is witnessing steady growth as consumers increasingly prefer preventive healthcare solutions over repeated antibiotic treatments. Rising awareness regarding recurrent UTIs, growing female healthcare expenditure, and the increasing availability of probiotic supplements, cranberry extracts, D-mannose formulations, urinary health supplements, and hygiene products are contributing significantly to market expansion. The growing prevalence of recurrent urinary tract infections among women, elderly individuals, pregnant women, and catheterized patients has accelerated the adoption of daily preventive healthcare products. Increasing concerns regarding antibiotic resistance have further shifted consumer preference to...